We look at medical technologies and consider their potential improving clinical outcomes competitively (including cost). Ultimately, we are interested in gauging the market outlook for industry participants so that we can identify opportunities and challenges. Occasionally, we have to point out challenges that really have less (if any) bearing on the technologies themselves [...]
bookmark to
